作者: David P. Mason , Sudish C. Murthy , Jang Wen Su , Thomas W. Rice
DOI: 10.1007/978-1-4419-1238-1_21
关键词: Lung cancer 、 Pulmonary vein 、 Surgery 、 Medicine 、 Lymph node sampling 、 Resection 、 Lymphadenectomy 、 Reduction (orthopedic surgery) 、 Malignant pleural effusion 、 Decreased inflammatory response
摘要: Minimally invasive thoracic surgical techniques appear to reduce important morbidity and facilitate return normal activity when compared with standard open approaches [1–3]. Mechanisms for this benefit likely include reduction in pain, earlier ambulation, decreased inflammatory response injury [3–6]. Before such are routinely adopted, however, it is incumbent upon surgeons demonstrate that therapeutic of the procedure not compromised. For resection lung cancer, means there must be comparable completeness appropriate lymph node sampling or lymphadenectomy [2, 7–9].